As of 3/31/2025, Tracenable has captured detailed data on Zydus Lifesciences's corporate ownership structure, providing a comprehensive view of its downstream entities and the role within the broader group hierarchy.a
The dataset includes information on 57 affiliated entities, encompassing subsidiaries, joint ventures, associates, and other related companies in which Zydus Lifesciences holds an equity interest or exercises control as the ultimate parent.a
Tracenable's data also records effective ownership percentages that Zydus Lifesciences holds across these entities, providing transparency into its corporate control, ownership hierarchy, and group governance practices.a
| Entity Name | Country | Type | Ownership | LEI | PermID |
|---|---|---|---|---|---|
German Remedies Pharmaceuticals Private Limiteda | IND | Subsidiary | 100% | 0000000 | 0000000 |
Naturell lnc.a | USA | Subsidiary | 57.59% | 0000000 | 0000000 |
Zydus Wellness Limiteda | IND | Subsidiary | 57.59% | 0000000 | 0000000 |
Zydus Pharmaceuticals UK Limiteda | GBR | Subsidiary | 100% | 0000000 | 0000000 |
Zydus Wellness Products Limiteda | IND | Subsidiary | 57.59% | 0000000 | 0000000 |
Zydus Healthcare SA (Pty) Ltd.a | ZAF | Subsidiary | 100% | 0000000 | 0000000 |
Liva Investment Limiteda | IND | Subsidiary | 57.59% | 0000000 | 0000000 |
LM Manufacturing Limiteda | GBR | Subsidiary | 100% | 0000000 | 0000000 |
Liva Nutritions Limiteda | IND | Subsidiary | 57.59% | 0000000 | 0000000 |
Oncosol Limiteda | GBR | Joint Venture | 50% | 0000000 | 0000000 |
Zydus Animal Health and Investments Limiteda | IND | Subsidiary | 100% | 0000000 | 0000000 |
Medsolutions (Europe) Limiteda | GBR | Subsidiary | 100% | 0000000 | 0000000 |
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| 0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| Showing 12 out of 57 entities. Get complete coverage in the full dataset. | |||||
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Zydus Lifesciences’s data sources below and access millions more through our Disclosure Search.
Tracenable's dataset provides geographic insights into Zydus Lifesciences's group entities, revealing where its subsidiaries, joint ventures, associates, and affiliates are located worldwide.a
In total, the Zydus Lifesciences group consists of 57 entities distributed across 18 countries, reflecting the company's global footprint and jurisdictional presence.a
This visualization highlights the geographical distribution of Zydus Lifesciences's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape.a
In 2025, Tracenable identified that the Zydus Lifesciences group consisted of 57 entities operating across 18 countries.a
This indicates a moderate geographic diversification, reflecting Zydus Lifesciences's expansion strategy, global footprint, and cross-border exposure.a
Zydus Lifesciences's subsidiaries and affiliates are primarily concentrated in Asia and Europe, which host 68.42% of its total entities.a
This regional distribution suggests that Zydus Lifesciences's operational and financial activities are centered in these markets, either due to core business operations, supply chain proximity, or favorable regulatory environments.
Zydus Lifesciences shows a moderate to high level of transparency regarding its ownership structure.
The disclosure includes information on subsidiaries, joint ventures, and associates, allowing partial visibility into the company's downstream relationships and areas of shared control.a
While not a full edge-level disclosure, the data still provides meaningful insight into Zydus Lifesciences's governance framework and group composition, positioning it among more transparent reporters in its industry.
No. Tracenable's data does not indicate any entities registered in jurisdictions typically categorized as low-tax or offshore financial centers, suggesting that Zydus Lifesciences's ownership network is primarily domiciled in standard corporate jurisdictions or that Zydus Lifesciences does not provide full transparency on its corporate structure.a